Herbal medicines in the treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD): An updated systematic review of clinical trials

Document Type : Review Article

Authors

1 Department of Traditional Medicine, School of Persian Medicine, Iran University of Medical Sciences, Tehran, Iran

2 Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Objective: This study was performed to provide an updated systematic review of herbal medicines and phytochemicals used for treatment of the pediatric patients with attention-deficit/hyperactivity disorder (ADHD).
Materials and Methods: International electronic databases, including Scopus, PubMed, ScienceDirect, and Google Scholar were investigated from 1st January 2000 to late October 2021. Interventional studies published in English language, including randomized controlled trials (RCTs) or open-label clinical studies, which evaluated the effect of herbal medicines and phytochemicals on pediatric ADHD were included in this review.
Results: Fifteen studies met the inclusion criteria. Several pieces of evidence support the efficacy of Ginkgo biloba L. and Pycnogenol; mainly inconclusive evidence could be found for Valeriana officinalis L., Melissa officinalis L., and ginseng. The results showed that while Hypericum perforatum L. was ineffective for ADHD, Passiflora incarnata L., Crocus sativus L, and Prunus dulcis (Mill.) D.A.Webb had similar efficacy compared to methylphenidate (MPH).
Conclusion: A number of herbal medicines appear to be relatively safe and provide potential efficacy in amelioration of ADHD. However, due to lack of adequate reports of RCTs, no definitely specific recommendations could been made so far.

Keywords


Akhondzadeh S, Mohammadi MR, Momeni F.
2005. Passiflora incarnata in the treatment
of attention-deficit hyperactivity disorder
in children and adolescents. Therapy, 2:
609-614.
Anheyer D, Lauche R, Schumann D, Dobos G,
Cramer H. 2017. Herbal medicines in
children with attention deficit
hyperactivity disorder (ADHD): A
systematic review. Complement Ther
Med, 30: 14-23.
Baeg IH, So SH. 2013. The world ginseng
market and the ginseng (Korea). J Ginseng
Res, 37: 1-7.
BarnesJ, Anderson LA, Phillipson JD. 2001. St
John's wort (Hypericum perforatum L.): a
review of its chemistry, pharmacology and
clinical properties. J Pharm Pharmacol, 53:
583-600.
Baziar S, Aqamolaei A, Khadem E, Mortazavi
SH, Naderi S, Sahebolzamani E,
Mortezaei A, Jalilevand S, Mohammadi
MR, Shahmirzadi M. 2019. Crocus sativus
L. versus methylphenidate in treatment of
children with attentiondeficit/hyperactivity disorder: A
randomized, double-blind pilot study. J
Child Adolesc Psychopharmacol, 29: 205-
212.
Brue AW, Oakland TD. 2002. Alternative
treatments for attentiondeficit/hyperactivity disorder: does
evidence support their use? Altern Ther
Health Med, 8: 68-74.
Bussing R, Zima BT, Gary FA, Garvan CW.
2002. Use of complementary and
alternative medicine for symptoms of
attention-deficit hyperactivity disorder.
Psychiatr Serv, 53: 1096-1102.
Carol Ho SW, Tong Chien W, Wang LQ. 2011.
Parents’ perceptions of care-giving to a
child with attention deficit hyperactivity
disorder: an exploratory study. Contemp
Nurse, 40: 41-56.
Curatolo P, Paloscia C, D'Agati E, Moavero R,
Pasini A. 2009. The neurobiology of
attention deficit/hyperactivity disorder.
Eur J Paediatr Neurol, 13: 299-304.
Dave UP, Dingankar SR, Saxena VS, Joseph
JA, Bethapudi B, Agarwal A, Kudiganti V.
2014. An open-label study to elucidate the
effects of standardized Bacopa monnieri
extract in the management of symptoms of
attention-deficit hyperactivity disorder in
children. Adv Mind-Body Med, 28: 10-15.
Diamond BJ, Shiflett SC, Feiwel N, Matheis
RJ, Noskin O, Richards JA, Schoenberger
NE. 2000. Ginkgo biloba extract:
mechanisms and clinical indications. Arch
Phys Med Rehabil, 81: 668-678.
Heal D, Cheetham S, Smith S. 2009. The
neuropharmacology of ADHD drugs in
vivo: insights on efficacy and safety.
Neuropharmacol, 57: 608-618.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P,
Moher D, Oxman AD, Savovic J, Schulz
KF, Weeks L, Sterne JA. 2011. Cochrane
bias methods group; cochrane statistical
methods group. Brit Med J, 343.
Iravani S, Zolfaghari B. 2011. Pharmaceutical
and nutraceutical effects of Pinus pinaster
bark extract. Res Pharm Sci, 6: 1-11.
Jawna‐Zboińska K, Blecharz‐Klin K, Joniec‐
Maciejak I, Wawer A, Pyrzanowska J,
Piechal A, Mirowska‐Guzel D, Widy‐
Tyszkiewicz E. 2016. Passiflora incarnata
L. improves spatial memory, reduces
stress, and affects neurotransmission in
rats. Phytother Res, 30: 781-789.
Karimi Z, Firouzi M, Dadmehr M, JavadMousavi SA, Bagheriani N, Sadeghpour
O. 2021. Almond as a nutraceutical and
therapeutic agent in Persian medicine and
modern phytotherapy: A narrative review.
Phytother Res, 35: 2997-3012.
Katz M, Adar Levine A, Kol-Degani H, KavVenaki L. 2010. A compound herbal
preparation (CHP) in the treatment of
children with ADHD: a randomized
controlled trial. J Atten Disord, 14: 281-
291.
Kemper KJ, Gardiner P, Birdee GS. 2013. Use
AJP, Vol. 13, No. 4, Jul-Aug 2023 352
Herbal medicines in the treatment of ADHD
of complementary and alternative medical
therapies among youth with mental health
concerns. Acad Pediatr, 13: 540-545.
Khaksarian M, Mirr I, Kordian S, Nooripour R,
Ahangari N, Masjedi-Arani A. 2021. A
comparison of methylphenidate (MPH)
and combined methylphenidate with
Crocus sativus (Saffron) in the treatment
of children and adolescents with ADHD: A
randomized, double-blind, parallel-group,
clinical trial. Iran J Psychiatry Behav Sci,
15: e108390.
Ko HJ, Kim I, Kim JB, Moon Y, Whang MC,
Lee KM, Jung SP. 2014. Effects of Korean
red ginseng extract on behavior in children
with symptoms of inattention and
hyperactivity/impulsivity: a double-blind
randomized placebo-controlled trial. J
Child Adolesc Psychopharmacol, 24: 501-
508.
Lyon MR, Cline JC, de Zepetnek JT, Shan JJ,
Pang P, Benishin C. 2001. Effect of the
herbal extract combination Panax
quinquefolium and Ginkgo biloba on
attention-deficit hyperactivity disorder: a
pilot study.J Psychiatry Neurosci, 26: 221-
228.
Miroddi M, Calapai G, Navarra M, Minciullo
PL, Gangemi S. 2013. Passiflora incarnata
L.: ethnopharmacology, clinical
application, safety and evaluation of
clinical trials. J Ethnopharmacol, 150:
791-804.
Moher D, Shamseer L, Clarke M, Ghersi D,
Liberati A, Petticrew M, Shekelle P,
Stewart LA. 2015. Preferred reporting
items for systematic review and metaanalysis protocols (PRISMA-P) 2015
statement. Syst Rev, 4: 1.
Moradkhani H, Sargsyan E, Bibak H, Naseri B,
Sadat-Hosseini M, Fayazi-Barjin A,
Meftahizade H. 2010. Melissa officinalis
L., a valuable medicine plant: A review. J
Med Plant Res, 4: 2753-2759.
Motaharifard MS, Effatpanah M, Akhondzadeh
S, Rahimi H, Yasrebi SA, Nejatbakhsh F.
2019. Effect of sweet almond syrup versus
methylphenidate in children with ADHD:
A randomized triple-blind clinical trial.
Complement Ther Clin Pract, 36: 170-175.
Niederhofer H. 2010. St. John's wort may
improve some symptoms of attentiondeficit hyperactivity disorder. Nat Prod
Res, 24: 203-205.
Ong WY, Farooqui T, Koh HL, Farooqui AA,
Ling EA. 2015. Protective effects of
ginseng on neurological disorders. Front
Aging Neurosci, 7: 129.
Pallucchini A, Carli M, Scarselli M,
Maremmani I, Perugi G. 2021.
Symptomatological variants and related
clinical features in adult attention deficit
hyperactive disorder. Int J Environ Res
Public Health, 18: 922.
Penland JG. 1994. Dietary boron, brain
function, and cognitive performance.
Environ Health Perspect, 102: 65-72.
Pizzorno L. 2015. Nothing boring about boron.
Integr Med (Encinitas), 14: 35-48.
Raman SR, Man KK, Bahmanyar S, Berard A,
Bilder S, Boukhris T, Bushnell G, Crystal
S, Furu K, KaoYang YH. 2018. Trends in
attention-deficit hyperactivity disorder
medication use: a retrospective
observational study using populationbased databases. Lancet Psychiat, 5: 824-
835.
Razlog R, Pellow J, White SJ. 2011. A pilot
study on the efficacy of Valeriana
officinalis mother tincture and Valeriana
officinalis 3X in the treatment of attention
deficit hyperactivity disorder. Health SA
Gesondheid, 17: 1-7.
Sahib ZH. 2014. Assessment of anxiolytic
activity of nuts of Prunus amygdalus
Dulcis (almond) in mice. Med J Babylon,
11: 817-824.
Salehi B, Imani R, Mohammadi MR, Fallah J,
Mohammadi M, Ghanizadeh A, Tasviechi
AA, Vossoughi A, Rezazadeh SA,
Akhondzadeh S. 2010. Ginkgo biloba for
attention-deficit/hyperactivity disorder in
children and adolescents: a double blind,
randomized controlled trial. Prog
Neuropsychopharmacol Biol Psychiatry,
34: 76-80.
Sarris J. 2007. Herbal medicines in the
treatment of psychiatric disorders: a
systematic review. Phytother Res, 21: 703-
716.
Sarris J, Kean J, Schweitzer I, Lake J. 2011.
Complementary medicines (herbal and
nutritional products) in the treatment of
Attention Deficit Hyperactivity Disorder
(ADHD): a systematic review of the
evidence. Complement Ther Med, 19:
216-227.
Schmidt M, Betti G, Hensel A. 2007. Saffron in
phytotherapy: pharmacology and clinical
uses. Wien Med Wochenschr, 157: 315-
AJP, Vol. 13, No. 4, Jul-Aug 2023 353
Golsorkhi et al.
319.
Shakibaei F, Radmanesh M, Salari E, Mahaki
B. 2015. Ginkgo biloba in the treatment of
attention-deficit/hyperactivity disorder in
children and adolescents. A randomized,
placebo-controlled, trial. Complement
Ther Clin Pract, 21: 61-67.
Simon V, Czobor P, Bálint S, Mészáros A,
Bitter I. 2009. Prevalence and correlates of
adult attention-deficit hyperactivity
disorder: meta-analysis. Br J Psychiatry,
194: 204-211.
Srivastava R, Ahmed H, Dixit RK. 2010.
Crocus sativus L.: a comprehensive
review. Pharmacogn Rev, 4: 200-208.
Tarver J, Daley D, Sayal K. 2014. Attention‐
deficit hyperactivity disorder (ADHD): an
updated review of the essential facts. Child
Care Health Dev, 40: 762-774.
Trebatická J, Kopasová S, Hradečná Z,
Činovský K, Škodáček I, Šuba J, Muchová
J, Žitňanová I, Waczulíková I, Rohdewald
P. 2006. Treatment of ADHD with French
maritime pine bark extract, Pycnogenol®.
Eur Child Adolesc Psychiatry, 15: 329-
335.
Uebel-von Sandersleben H, Rothenberger A,
Albrecht B, Rothenberger LG, Klement
S, Bock N. 2014. Ginkgo biloba extract
EG 761® in children with ADHD. Z
Kinder Jugendpsychiatr Psychother, 42:
337-347.
Weber W, Vander Stoep A, McCarty RL, Weiss
NS, Biederman J, McClellan J. 2008.
Hypericum perforatum (St John's wort) for
attention-deficit/hyperactivity disorder in
children and adolescents: a randomized
controlled trial. JAMA, 299: 2633-2641.
Wong YW, Kim DG, Lee JY. 2012. Traditional
oriental herbal medicine for children and
adolescents with ADHD: a systematic
review. J Evid Based Complementary
Altern Med, 2012: 520198